Literature DB >> 22480926

Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity.

Fernanda Rodrigues1, Dona Foster, Francisco Caramelo, Pedro Serranho, Guilherme Gonçalves, Luís Januário, Adam Finn.   

Abstract

OBJECTIVES: To track ongoing trends in pneumococcal (Sp) serotype carriage under the selection pressure of moderate pneumococcal conjugate vaccine (PCV) use, children in a community in Portugal were studied in the same months in 3 consecutive years.
METHODS: Nasopharyngeal specimens were collected (children aged 3 months to <7 years) in 8 urban daycare centers in February 2008 (n=561) and 2009 (n=585). Sp isolates were serotyped.
RESULTS: While demographics were similar in 2008-2009 and a previously reported sample in 2007, PCV coverage (at least one dose) in the children studied rose from 76.5% to 84% although national coverage was lower than this. Sp carriage fell from 61% to 51% with a concomitant fall in PCV7 serotype carriage from 12.1% to 4.3%. Remaining PCV7 serotypes declined to near (23F) or totally (6B, 14) undetectable levels except 19F which persisted unchanged in around 4% of children. Although carriage of 3 and 6C rose, there was no net increase in non-PCV7 serotypes and no progressive trend in serotype diversity.
CONCLUSIONS: Ecological changes induced by PCVs where uptake is moderate appear to be different from high usage settings. We report falling Sp carriage due to PCV7 serotype disappearance with persistence of 19F and no ongoing net replacement after several years of PCV7 use and slowly rising uptake.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480926     DOI: 10.1016/j.vaccine.2012.03.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens.

Authors:  E del Amo; L Selva; M F de Sevilla; P Ciruela; P Brotons; M Triviño; S Hernandez; J J Garcia-Garcia; Á Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

2.  Nasopharyngeal carriage of Streptococcus pneumoniae among children in an urban setting in Brazil prior to PCV10 introduction.

Authors:  Ana Paula de O Menezes; Jailton Azevedo; Mariela C Leite; Leila C Campos; Marcelo Cunha; Maria da Gloria S Carvalho; Mitermayer G Reis; Albert I Ko; Daniel M Weinberger; Guilherme Ribeiro; Joice N Reis
Journal:  Vaccine       Date:  2015-12-29       Impact factor: 3.641

3.  Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.

Authors:  Johannes Trück; Matthew D Snape; Florencia Tatangeli; Merryn Voysey; Ly-Mee Yu; Saul N Faust; Paul T Heath; Adam Finn; Andrew J Pollard
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

4.  Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial).

Authors:  Patricia B Pavlinac; Benson O Singa; Grace C John-Stewart; Barbra A Richardson; Rebecca L Brander; Christine J McGrath; Kirkby D Tickell; Mary Amondi; Doreen Rwigi; Joseph B Babigumira; Sam Kariuki; Ruth Nduati; Judd L Walson
Journal:  BMJ Open       Date:  2017-12-29       Impact factor: 2.692

5.  Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.

Authors:  Catarina Silva-Costa; Maria João Brito; Marcos D Pinho; Ana Friães; Sandra I Aguiar; M Ramirez; Jose Melo-Cristino
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

6.  Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK.

Authors:  Rebecca A Gladstone; Vanessa Devine; Jessica Jones; David Cleary; Johanna M Jefferies; Stephen D Bentley; Saul N Faust; Stuart C Clarke
Journal:  Microb Genom       Date:  2017-06-09

Review 7.  Respiratory risks from household air pollution in low and middle income countries.

Authors:  Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin
Journal:  Lancet Respir Med       Date:  2014-09-02       Impact factor: 30.700

8.  How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.

Authors:  Ine Wouters; Stefanie Desmet; Liesbet Van Heirstraeten; Sereina A Herzog; Philippe Beutels; Jan Verhaegen; Herman Goossens; Pierre Van Damme; Surbhi Malhotra-Kumar; Heidi Theeten
Journal:  Euro Surveill       Date:  2020-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.